Liisa Volin

Research interests

Publications

• Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

  Blood · 2017 · https://doi.org/10.1182/blood-2016-06-724500

• Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2016.70.7349

• Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

  Haematologica · 2014 · https://doi.org/10.3324/haematol.2014.116954

• CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

  Blood · 2013 · https://doi.org/10.1182/blood-2013-05-499830

• Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

  Blood · 2013 · https://doi.org/10.1182/blood-2012-11-469452

• Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen—A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2013.48.8114

• Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.36.9868

• Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up

  Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.32.7312

• Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

  Blood · 2011 · https://doi.org/10.1182/blood-2011-01-329821

• Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

  Blood · 2010 · https://doi.org/10.1182/blood-2010-02-266551

• Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

  The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70225-6

• Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion: A Retrospective European Group for Blood and Marrow Transplantation Analysis

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.16.2982

• Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.11.6053

• Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

  Blood · 2002 · https://doi.org/10.1182/blood-2001-12-0159

• Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

  Blood · 2002 · https://doi.org/10.1182/blood.v99.8.3050

• Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

  British Journal of Haematology · 2001 · https://doi.org/10.1046/j.1365-2141.2001.02726.x

• Increased Risk of Chronic Graft-Versus-Host Disease, Obstructive Bronchiolitis, and Alopecia With Busulfan Versus Total Body Irradiation: Long-Term Results of a Randomized Trial in Allogeneic Marrow Recipients With Leukemia

  Blood · 1999 · https://doi.org/10.1182/blood.v93.7.2196

• Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

  Bone Marrow Transplantation · 1997 · https://doi.org/10.1038/sj.bmt.1700737

• Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

  Blood · 1996 · https://doi.org/10.1182/blood.v88.12.4711.bloodjournal88124711

• A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

  Blood · 1994 · https://doi.org/10.1182/blood.v83.9.2723.2723

• Allogeneic Bone Marrow Transplantation in Multiple Myeloma

  New England Journal of Medicine · 1991 · https://doi.org/10.1056/nejm199110313251802

Current projects

No projects listed.